Catalyst Wire Dossier Catalyst Wire Dossier

VYD2311

· Invivyd, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for VYD2311, covering 2024-11-19 to 2026-06-10. Get the full timeline:

Most recent: Clinical Trial Update: Study of VYD2311 for the Prevention of COVID-19 [Phase 3]

See pricing